Enliven Therapeutics, Inc. (ELVN) Stock Price History
Historical prices from 2020 to 2026
- 1M
- +51.4%
- 3M
- +18.0%
- YTD
- +227.7%
- 1Y
- +159.9%
- 3Y
- +42.1%
- 5Y
- +11.6%
Loading 10-year price history...
ELVN Historical Performance
ELVN Annual Returns
Year-by-year price performance · 2020–2026
- 2020 annual price return
- +47.0%
- 2021 annual price return
- -90.6%
- 2022 annual price return
- +69.7%
- 2023 annual price return
- -12.2%
- 2024 annual price return
- +51.0%
- 2025 annual price return
- -35.6%
- 2026 annual price return
- +91.1%
ELVN Stock Price Trajectory (2020–2026)
As of July 8, 2026, Enliven Therapeutics, Inc. (ELVN) trades at $50.92, representing a +159.9% return over the past year. The stock has delivered a +73.0% total return over five years (+11.6% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $250.84 on June 9, 2020. From this peak, ELVN has corrected -79.7%, currently trading 70% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers KYMR (+172.2% 1Y), RVMD (+419.4% 1Y), and IMVT (+144.2% 1Y), ELVN has underperformed the peer group average. Compare ELVN vs KYMR →
ELVN Historical Price Data · from 2020
Rows 1–50 of 1,588| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-07-07 | 50.23 | 52.38 | 49.83 | 50.92 | 1.98M | +1.82% |
| 2026-07-06 | 49.46 | 51.39 | 49.46 | 50.01 | 719K | +0.38% |
| 2026-07-02 | 48.93 | 50.21 | 47.45 | 49.82 | 757K | +2.17% |
| 2026-07-01 | 51.20 | 51.84 | 48.13 | 48.76 | 1.06M | -3.92% |
| 2026-06-30 | 51.49 | 52.39 | 50.35 | 50.75 | 1.93M | -0.20% |
| 2026-06-29 | 50.39 | 51.05 | 49.39 | 50.85 | 1.54M | +1.54% |
| 2026-06-26 | 49.02 | 50.38 | 48.47 | 50.08 | 0 | +1.95% |
| 2026-06-25 | 48.09 | 50.55 | 47.19 | 49.12 | 2.75M | +2.83% |
| 2026-06-24 | 48.86 | 49.94 | 46.88 | 47.77 | 2.22M | -1.71% |
| 2026-06-23 | 45.01 | 48.79 | 45.01 | 48.60 | 1.91M | +5.74% |
| 2026-06-22 | 45.26 | 48.52 | 45.26 | 45.96 | 1.89M | +1.91% |
| 2026-06-18 | 45.01 | 45.72 | 44.22 | 45.10 | 2.16M | +0.53% |
| 2026-06-17 | 42.72 | 44.95 | 42.27 | 44.86 | 1.21M | +5.43% |
| 2026-06-16 | 42.51 | 44.02 | 40.95 | 42.55 | 3.42M | +0.45% |
| 2026-06-15 | 46.64 | 47.00 | 41.49 | 42.36 | 2.70M | -8.17% |
| 2026-06-12 | 39.77 | 47.36 | 39.00 | 46.13 | 6.14M | +14.30% |
| 2026-06-11 | 45.52 | 45.52 | 40.24 | 40.36 | 4.95M | +9.08% |
| 2026-06-10 | 36.15 | 37.41 | 35.71 | 37.00 | 1.26M | +2.46% |
| 2026-06-09 | 34.40 | 36.20 | 34.20 | 36.11 | 1.55M | +7.37% |
| 2026-06-08 | 35.45 | 35.79 | 33.45 | 33.63 | 804K | -3.11% |
| 2026-06-05 | 35.49 | 35.85 | 33.72 | 34.71 | 1.07M | -2.20% |
| 2026-06-04 | 36.00 | 38.01 | 35.47 | 35.49 | 998K | -1.50% |
| 2026-06-03 | 35.40 | 36.23 | 34.90 | 36.03 | 680K | +1.44% |
| 2026-06-02 | 37.30 | 37.53 | 35.43 | 35.52 | 1.69M | -5.31% |
| 2026-06-01 | 38.82 | 39.66 | 36.85 | 37.51 | 687K | -5.21% |
| 2026-05-29 | 40.65 | 40.94 | 39.02 | 39.57 | 717K | -2.66% |
| 2026-05-28 | 41.48 | 41.49 | 40.44 | 40.65 | 295K | -1.84% |
| 2026-05-27 | 42.67 | 42.99 | 41.31 | 41.41 | 440K | -2.63% |
| 2026-05-26 | 42.04 | 42.59 | 40.75 | 42.53 | 533K | +2.38% |
| 2026-05-22 | 42.80 | 43.05 | 41.43 | 41.54 | 616K | -1.68% |
| 2026-05-21 | 41.59 | 42.89 | 40.80 | 42.25 | 904K | +0.93% |
| 2026-05-20 | 40.56 | 42.39 | 40.30 | 41.86 | 620K | +4.21% |
| 2026-05-19 | 39.82 | 40.25 | 38.76 | 40.17 | 609K | +1.36% |
| 2026-05-18 | 41.34 | 41.78 | 38.78 | 39.63 | 509K | -4.14% |
| 2026-05-15 | 42.95 | 42.95 | 41.07 | 41.34 | 493K | -4.04% |
| 2026-05-14 | 42.30 | 43.58 | 42.12 | 43.08 | 563K | -1.10% |
| 2026-05-13 | 42.24 | 45.14 | 40.92 | 43.56 | 1.05M | +2.98% |
| 2026-05-12 | 40.65 | 43.28 | 40.01 | 42.30 | 1.13M | +6.85% |
| 2026-05-11 | 41.51 | 42.00 | 39.34 | 39.59 | 693K | -2.85% |
| 2026-05-08 | 41.84 | 42.91 | 40.02 | 40.75 | 576K | +1.14% |
| 2026-05-07 | 41.33 | 41.33 | 39.54 | 40.29 | 456K | -2.21% |
| 2026-05-06 | 41.84 | 42.33 | 40.76 | 41.20 | 340K | -0.91% |
| 2026-05-05 | 41.69 | 42.99 | 40.72 | 41.58 | 393K | -0.07% |
| 2026-05-04 | 41.71 | 42.16 | 41.16 | 41.61 | 341K | -0.22% |
| 2026-05-01 | 41.26 | 43.57 | 40.06 | 41.70 | 448K | +1.14% |
| 2026-04-30 | 42.35 | 43.43 | 40.69 | 41.23 | 807K | -2.76% |
| 2026-04-29 | 42.72 | 43.84 | 42.00 | 42.40 | 387K | -1.35% |
| 2026-04-28 | 44.84 | 45.31 | 42.77 | 42.98 | 612K | -4.28% |
| 2026-04-27 | 44.50 | 46.85 | 44.35 | 44.90 | 601K | +1.47% |
| 2026-04-24 | 44.00 | 44.53 | 43.26 | 44.25 | 615K | +0.82% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ELVN — Frequently Asked Questions
Quick answers to the most common questions about buying ELVN stock.
How has ELVN stock performed recently?
ELVN returned +159.9% over the past year, beating its 5-year annualized CAGR of +11.6%. The stock trades above its 200-day moving average, confirming the uptrend.
What is ELVN's all-time high price?
Enliven Therapeutics, Inc. reached $250.84 on 2020-06-09. The 52-week high is $52.39. Current 1-year return of +159.9% places the stock closer to historical peaks.
Where can I download ELVN historical price data?
This page provides ELVN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.